ACUTA CAPITAL PARTNERS, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1582844 REDWOOD CITY, CA

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,825,912

+$1,861,508 QoQ

Shares Held

561,808

+27.8% QoQ

Ownership

0.172%

of shares outstanding

% of Portfolio

2.67%

of 13F equity value

Holder Rank

#53

of 208 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACUTA CAPITAL PARTNERS, LLC holds $139,270,289 across 21 Biotechnology names. TSHA ranks #15 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	82,796	$27,719,272
2	WHWK	Whitehawk Therapeutics, Inc.	4,685,912	$21,461,476
3	TNGX	Tango Therapeutics, Inc.	390,949	$12,221,065
4	STRO	Sutro Biopharma, Inc.	270,251	$8,972,333
5	AVBP	ArriVent BioPharma, Inc.	218,694	$7,597,429
6	FDMT	4D Molecular Therapeutics, Inc.	507,801	$6,753,753
7	DRUG	Bright Minds Biosciences Inc.	92,745	$6,510,699
8	OCUL	Ocular Therapeutix, Inc	532,481	$5,228,963

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,825,912	561,808	+27.8%	Shares	Sole	2026-08-14
2026-03-31	$1,964,404	439,464	-3.4%	Shares	Sole	2026-05-15
2025-12-31	$2,501,548	454,827	0.0%	Shares	Sole	2026-02-17
2025-09-30	$1,487,284	454,827	-6.4%	Shares	Sole	2025-11-14
2025-06-30	$1,121,895	485,669	-45.1%	Shares	Sole	2025-08-14
2024-12-31	$1,529,742	884,244	-58.3%	Shares	Sole	2025-02-14
2024-09-30	$4,259,173	2,118,992	-9.1%	Shares	Sole	2024-11-14
2024-06-30	$5,221,298	2,330,937	-30.1%	Shares	Sole	2024-08-14
2024-03-31	$9,566,665	3,333,333	-7.1%	Shares	Sole	2024-05-15
2023-12-31	$6,353,119	3,589,333	-6.2%	Shares	Sole	2024-02-14
2023-09-30	$12,096,246	3,827,926	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.